NeOnc Technologies Holdings is trading 5.9% up at $5.20, extending a volatile advance after rising 16.35% on August 17 and 31.46% on August 14.
- No new company announcement dated August 18, 2026, was found.
- The latest identifiable catalyst remains the August 12 NEO100 Phase 2a readout, which reported a 48.9% six-month progression-free survival rate.
- Available sources do not explicitly attribute today’s move to that update.